| 3R91: Macrocyclic Lactams As Potent Hsp90 Inhibitors With Excellen Exposure And Extended Biomarker Activity. reference: Macrocyclic lactams as potent Hsp90 inhibitors with excellent tumor exposure and extended biomarker activity., Zapf CW, Bloom JD, McBean JL, Dushin RG, Nittoli T, Otteng M, Ingalls C, Golas JM, Liu H, Lucas J, Boschelli F, Hu Y, Vogan E, Levin JI, Bioorg Med Chem Lett. 2011 Apr 5. PMID: 21515049 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).